Back to Point72 Asset Management, L.P. Point72 Asset Management, L.P.

GLPGGLPG
20 quarters

Position history for Point72 Asset Management, L.P.Point72 Asset Management, L.P.'s holdings in LAKEFRONT BIOTHERAPEUTICS NV

Yes. Point72 Asset Management holds 269,814 shares of GLPG (Lakefront Biotherapeutics), worth $8.1M, as of its Q2 2026 13F filing. It reduced the position by 62,311 shares (-18.8%) from Q1 2026. Point72 Asset Management has held GLPG since Q2 2025, across 5 quarterly 13F filings.

Current Value

$8.1M

Current Shares

269,814

Total Value Change

-$17.6M

Total Shares Change

+10,614

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
269,814
-18.8%
$8.1M0.0%$27.73
0
2026-Q1
Decreased
332,125
-31.7%
$10M0.0%$33.05
0
2025-Q4
Increased
486,209
+9.5%
$15.9M0.0%$32.61
31
2025-Q3
Increased
443,869
+30.0%
$15.4M0.0%$34.43
35
2025-Q2
New
341,500
-
$9.6M0.0%$27.98
38
2024-Q2
Exited
0
-100.0%
$00.0%$24.78
0
2024-Q1
Decreased
53,700
-65.3%
$1.7M0.0%$32.20
0
2023-Q4
Decreased
154,649
-10.8%
$6.3M0.0%$40.65
0
2023-Q3
Decreased
173,300
-80.3%
$6M0.0%$34.55
0
2023-Q2
Increased
880,668
+23.1%
$35.8M0.1%$40.38
42
2023-Q1
Increased
715,600
+1198.7%
$27.7M0.1%$37.53
46
2022-Q4
Increased
55,100
+293.6%
$2.4M0.0%$44.38
42
2022-Q3
New
14,000
-
$597,0000.0%$42.27
34
2022-Q2
Exited
0
-100.0%
$00.0%$55.62
0
2022-Q1
Decreased
509,800
-33.3%
$31.6M0.1%$64.26
0
2021-Q4
Increased
763,900
+547.9%
$42.1M0.2%$55.48
56
2021-Q3
Decreased
117,900
-83.4%
$6.2M0.0%$52.17
0
2021-Q2
Increased
712,156
+53.0%
$49.1M0.2%$70.14
49
2021-Q1
Increased
465,478
+79.6%
$35.9M0.2%$76.44
53
2020-Q4
New
259,200
-
$25.7M0.1%$99.82
47

Other major holders of GLPG: SANDS CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used